Parkman Healthcare Partners’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11M Sell
12,676
-23,679
-65% -$21.1M 1.13% 29
2025
Q4
$29.8M Buy
36,355
+7,813
+27% +$6.38M 2.84% 6
2025
Q3
$22M Buy
28,542
+11,084
+63% +$7.81M 2.3% 11
2025
Q2
$12.8M Sell
17,458
-4,643
-21% -$3.28M 1.47% 22
2025
Q1
$14.9M Sell
22,101
-899
-4% -$556K 1.76% 20
2024
Q4
$13.1M Buy
+23,000
New +$12.9M 1.75% 20

Other funds holding MCK

Parkman Healthcare Partners's MCK Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its McKesson (MCK) stake by 65% in Q1 2026, selling an estimated $21.1M and leaving 12,676 shares worth $11M. The position accounts for 1.13% of the portfolio, ranked #29.

Parkman Healthcare Partners first reported a position in MCK in Q4 2024 and has held it in 6 quarters since. The position peaked at $29.8M in Q4 2025. 2,034 funds tracked by Wall St. Rank hold MCK as of Q1 2026.

  • Parkman Healthcare Partners held 12,676 shares of McKesson worth $11M as of Q1 2026.
  • Parkman Healthcare Partners sold 23,679 McKesson shares in Q1 2026, an estimated $21.1M.
  • McKesson made up 1.13% of Parkman Healthcare Partners's portfolio in Q1 2026, its #29 holding.
  • Parkman Healthcare Partners first reported a position in McKesson in Q4 2024 and has held it in 6 quarters since.
  • Parkman Healthcare Partners's McKesson position peaked at $29.8M in Q4 2025.
  • 2,034 funds tracked by Wall St. Rank held McKesson as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.